Oncoclínicas Q2 Loss More Than Triples to US$91 Million
Brazil's largest cancer-care group, Oncoclínicas, saw its Q2 2026 net loss more than triple to R$475.7 million (about US$91 million) as revenue fell and drug shortages hit its clinics. The post Oncoclínicas Q2 Loss More Than Triples to US$91 Million appeared first on The Rio Times .
Read the full story at The Rio Times →